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A dileucine motif in HIV-1 Nef acts as an internalization signal
for CD4 downregulation and binds the AP-1 clathrin adaptor
Patricia A. Bresnahan*†‡, Wes Yonemoto*†, Sharon Ferrell*, 
Debora Williams-Herman§, Romas Geleziunas* and Warner C. Greene*‡¶
Human immunodeficiency virus 1 (HIV-1) Nef
downregulates surface expression of CD4, an integral
component of the functional HIV receptor complex,
through accelerated endocytosis of surface receptors and
diminished transport of CD4 from the Golgi network to
the plasma membrane [1–3]. HIV-1 Nef also diminishes
surface expression of major histocompatibility complex
(MHC) class I antigens [4]. In the case of HIV-2 and
simian immunodeficiency virus 1 (SIV-1) Nef, amino-
terminal tyrosine-based motifs mediate the binding of
Nef to the AP-1 and AP-2 adaptors and this interaction
appears to be required for CD4 downregulation [5,6]. As
these tyrosine motifs are not present in the HIV-1 Nef
protein, the molecular basis for the presumed interaction
of Nef with components of the endocytic machinery is
unknown. Here, we identify a highly conserved dileucine
motif in HIV-1 Nef that is required for downregulation of
CD4. This motif acts as an internalization signal in the
context of a CD8–Nef chimera or in a fusion of the
interleukin-2 receptor awith an 11-amino-acid region
from Nef containing the dileucine motif. Finally, HIV-1 Nef
binds to the AP-1 adaptor, both in vitro and in vivo, in a
dileucine-dependent manner. We conclude that this
conserved dileucine motif in HIV-1 Nef serves as a key
interface for interaction with components of the host
protein trafficking machinery. Our findings also reveal an
evolutionary difference between HIV-1 and HIV-2/SIV in
which the Nef proteins utilize structurally distinct motifs
for binding cellular adaptors.
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Results and discussion
Three distinct regions in HIV-1 Nef that contribute 
to CD4 downregulation have been identified: two 
disordered loops of unknown function located at amino
acids 2–39 and 148–180, and a potential CD4-binding site
formed by two discontinuous sequences within the core
structure of Nef [7–9]. In HIV-1 NL4-3 Nef, a highly
conserved dileucine motif is located at residues 164–165
in the second disordered loop. This motif shares proper-
ties associated with other dileucine-based internalization
signals, including an upstream acidic residue [10] and a
proximal proline residue (at positions 160 and 167,
respectively, in NL4-3 Nef) potentially associated with a
β-turn structure [11].
To determine whether this dileucine motif and flanking
sequences in HIV-1 Nef function in CD4 downregulation,
we used NL4-3 Nef mutants in which these amino acids
were replaced with alanine residues: Nef L164A/L165A
(Nef LL/AA), Nef E160A and Nef P167A (in the single-
letter amino-acid code). Using flow cytometry to quantitate
cell-surface expression of CD4 on human 293 cells, we
observed that the Nef LL/AA mutant was impaired for
CD4 downregulation compared with wild-type Nef
(Figure 1). Similarly, mutation of comparable leucines in
the SF2 allele of Nef inhibited CD4 downregulation (data
not shown). The E160A and P167A mutations did not
disable Nef for CD4 downregulation, but a composite
R35A/D36A/D174A/D175A mutant (altered at amino acids
in the two disordered loops) failed to downregulate CD4.
Thus, in addition to other structural elements, HIV-1 Nef
requires a conserved dileucine motif (at residues 164–165
of NL4-3 Nef) to downregulate CD4.
The role of the dileucine motif in Nef in directing intra-
cellular protein traffic was further evaluated by prepar-
ing a chimera composed of the extracellular and
transmembrane domains of human CD8 and a cytoplas-
mic tail of either wild-type Nef or Nef LL/AA
sequences. Such chimeras have served as valuable tools
for examining internalization signals within Nef [3,12].
By flow cytometry, the percentage of CD8–Nef LL/AA
transfected cells bearing cell-surface CD8 was approxi-
mately four times greater than for cells transfected with
CD8–Nef (wild-type), and was comparable to the cell-
surface expression of CD8 in cells transfected with CD8
alone (Figure 2a). These findings suggest that the
CD8–Nef LL/AA mutant is preferentially expressed at
the cell surface compared with CD8–Nef. Analysis of
whole-cell lysates demonstrated equivalent amounts of
CD8–Nef and CD8–Nef LL/AA at steady-state expres-
sion (Figure 2c).
The decrease in cell-surface expression of CD8–Nef rela-
tive to CD8–Nef LL/AA could reflect either retention of
the chimera in the biosynthetic pathway or enhanced endo-
cytosis from the cell surface. To investigate whether the
dileucine sequence has a role in the rate of endocytosis, we
compared the rates of internalization of CD8–Nef and
CD8–Nef LL/AA chimeras (Figure 2b). CD8–Nef was
internalized nearly four times more rapidly than CD8–Nef
LL/AA. These results support the notion that the dileucine
motif serves as an internalization signal and that the
enhanced surface expression of CD8–Nef LL/AA derives at
least in part from its diminished rate of endocytosis. 
To determine whether the dileucine motif in Nef is suffi-
cient to stimulate endocytosis, we created a chimeric
protein composed of the IL-2 receptor α chain (IL-2Rα)
fused at its cytoplasmic carboxyl terminus to an 11-amino-
acid segment (GENTSLLHPVS) of HIV-1 Nef contain-
ing the dileucine motif (IL-2Rα–LL) or lacking it
(IL-2Rα–AA). The IL-2Rα protein has a short cytoplas-
mic tail of 13 amino acids which lacks an internalization
signal and it is not efficiently endocytosed via clathrin-
coated pits. Using flow cytometry to measure the rate of
internalization [3], we found that IL-2Rα–LL was inter-
nalized nearly five times faster than IL-2Rα–AA (Figure
3). These results demonstrate that the 11-amino-acid
segment of Nef spanning the dileucine motif forms an
effective internalization signal when presented on the
cytoplasmic tail of a chimeric transmembrane protein. 
We next investigated whether HIV-1 Nef physically
interacts with components of the endocytic machinery
via this dileucine motif. HeLa cell lysates were incu-
bated with a series of glutathione-S-transferase
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Figure 1
Relative expression of CD4 in human 293 cells after transient
expression in the absence (lane 2) or presence (lanes 3–7) of HIV-1
NL4-3 Nef or the indicated mutants. Values are the average of two
independent transfections. Cells were stained with FITC-conjugated
anti-CD4 antibodies (Becton Dickinson). Positively stained cells were
determined as having a higher fluorescence level than 98% of cells
stained with a non-CD4 antibody of matched isotype. Lane 2
represents the percentage of cells that scored positive for surface
CD4 expression in the absence of Nef after transfection. Relative
expression of Nef and the mutant Nef proteins from the same
experiment, as detected by immunoblotting of whole-cell lysates with
anti-Nef rabbit serum GF7, is shown above, in lanes 2–7 (the position
of bands accurately reflects relative mobility). Lane 1 represents a
mock-transfected sample as a control.
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Figure 2
(a) Relative expression of truncated CD8 and CD8–Nef chimeras on
the surface of transfected human 293 cells stained with FITC-
conjugated anti-CD8 antibodies (Becton Dickinson). Results represent
the mean of three independent transfections. Similar results were
obtained in at least three independent experiments. (b) Receptor
internalization determined using an assay based on fluorescence-
activated cell sorting (FACS) [3]. The amount of receptor
internalization was calculated as the percentage difference in the mean
channel fluorescence at each time point compared with mean channel
fluorescence at time zero. (c) Relative expression of total cellular
CD8–Nef (lane 3) or CD8–Nef LL/AA (lane 4) as detected by
immunoblotting with anti-Nef rabbit serum GF7. Whole-cell lysates
were prepared from parallel wells of 293 cells used for internalization
measurements and were separated by SDS–PAGE. Lysates from
mock-transfected cells (lane 1) or cells transfected with CD8 (lane 2)
were also analyzed as controls. 
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(GST)–Nef fusion proteins and bound proteins were
separated by SDS–PAGE. The presence of AP-1 and
AP-2 was evaluated by immunoblotting with specific
antibodies. AP-1 adaptor bound to wild-type Nef but not
to Nef LL/AA or to GST alone (Figure 4a). In contrast,
Nef R35A/D36A/D174A/D175A, which fails to downreg-
ulate CD4, effectively bound to AP-1, suggesting that its
defect is distinct from that in the Nef LL/AA mutant.
AP-1 also bound to the Nef E160A and Nef P167A
mutants, although the E160A mutant consistently cap-
tured less AP-1. To ensure that the dileucine mutant of
Nef did not disrupt its overall structure, we tested the
ability of Nef LL/AA to bind p59Hck. The p59Hck
protein interacts with Nef at the proline-rich SH3-ligand
domain situated at amino acids 69–73 [13]. Notably, the
Nef LL/AA continued to bind p59Hck, indicating that
the dileucine substitution did not cause a gross change
in conformation (Figure 4a). Together, these studies
demonstrate that HIV-1 Nef physically interacts 
with the AP-1 adaptor complex in vitro in a dileucine-
dependent manner. 
We were unable to detect similar binding of HIV-1 Nef to
AP-2 under comparable conditions. In this regard, others
have also failed to detect an interaction between HIV-1
Nef and AP-2 by the yeast two-hybrid method or by
immunoprecipitation under physiological salt conditions
[4,5,14]. However, a fusion protein composed of HIV-1
Nef and green fluorescent protein (GFP) colocalizes with
AP-2 at the plasma membrane [15]. We suspect that our
failure to detect AP-2 binding is due to a lower affinity of
Nef for this adaptor than for AP-1.
To establish whether AP-1 physically interacts with Nef in
vivo, we transiently expressed the CD8–Nef or CD8–Nef
LL/AA proteins in human 293 cells and immunoprecipi-
tated the fusion proteins with anti-CD8 antibodies. Subse-
quent detection of AP-1 confirmed that this adaptor
co-immunoprecipitated with the CD8–Nef protein but
not with CD8–Nef LL/AA or with native CD8
(Figure 4b). Binding of AP-2 with CD8–Nef was not
detected under these conditions. These findings demon-
strate the in vivo association of HIV-1 Nef with the AP-1
clathrin adaptor. 
In the trans-Golgi network, AP-1 recruits clathrin to form
vesicles that transit to a recycling endosome compartment
for further sorting to the plasma membrane or to lysosomes
or for return to the Golgi (reviewed in [16]). Sorting of host
proteins in the endosomal compartment involves the
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Figure 3
Internalization of IL-2Rα chimeras in human 293 cells. An 11-amino-
acid segment (GENTSLLHPVS) of HIV-1 Nef containing the dileucine
motif and flanking residues (designated IL-2Rα–LL), or the same
peptide with alanines substituted for the leucines (IL-2Rα–AA), was
fused to IL-2Rα. Assays were conducted as described in Figure 2b,
except that the cells were stained with anti-CD25–RPE (Caltag). 
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Figure 4
(a) Binding of AP-1 to GST–Nef fusion proteins. GST (lane 1) or
GST–Nef wild-type (lane 2), GST–Nef LL/AA (lane 3), GST–Nef
E160A (lane 4), GST–Nef P167A (lane 5) or GST–Nef
R35A/D36A/D174A/D175A (lane 6) immobilized on Sepharose beads
were incubated with HeLa cell lysates. For lanes 1–6, bound proteins
were eluted and separated by SDS–PAGE, and immunoblotted with
100/3 antibody specific for AP-1 subunit γ (AP-1γ, Sigma). As a
control, purified adaptors from bovine brain were loaded onto the same
gel (lane 7). In a separate experiment, GST (lane 8), GST–Nef (lane 9)
or GST–Nef LL/AA Sepharose beads were incubated with lysates
from human 293 cells that were transiently transfected with p59Hck
(lanes 8–10). Bound proteins were separated as above and
immunoblotted with an antibody specific for p59Hck (Transduction
Laboratories). (b) Co-immunoprecipitation of CD8–Nef chimeras with
AP-1. Human 293 cells were transiently transfected under mock
conditions (lanes 1,2) or with CD8–Nef wild-type (lanes 3,4),
CD8–Nef LL/AA (lane 5) or CD8–Nef R35A/D36A/D174A/D175A
(lane 6). Purified adaptors were used as a control (lane 7). Whole-cell
lysates were immunoprecipitated with either control isotype-matched
antibody (lanes 1,3), or with anti-CD8 antibody OKT8 (gift of Art
Weiss; lanes 2,4–7). Immune complexes were bound to Pansorbin
(Calbiochem) coated with rabbit anti-mouse IgG antibody (Zymed).
The bound proteins were separated by SDS–PAGE and
immunoblotted with anti-AP-1γ antibody as in (a). 
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vesicle coat proteins, although the molecular mechanism is
not clearly understood. The physical association of HIV
Nef with AP-1 may serve to redirect sorting and exit of host
proteins, such as CD4 and MHC class I molecules, from the
Golgi or from endosomes. In the presence of Nef, CD4 is
redistributed to lysosomes [17,18] and is also disrupted in
transit from the Golgi to the plasma membrane [1,3].
Several biological functions, in addition to downregulation
of cell-surface CD4 and MHC class I molecules, have
been attributed to Nef. For example, HIV-1 Nef enhances
the infectivity of HIV virions [19,20], modulates receptor
signaling through the T-cell receptor complex (reviewed
in [21]) and expands the lysosomal and endosomal com-
partments within the cell [22]. The biochemical basis for
these diverse functions remains unknown. It is interesting
to consider the possibility that these various Nef functions
may result from interactions with AP-1 and possibly other
cellular adaptors, which are regulated by phosphorylation
events. Consistent with its association with various cellular
kinases, Nef may mediate the phosphorylation of regula-
tory proteins in the cell-sorting machinery. Such a model
could provide a unifying explanation for Nef’s diverse
effects on cellular physiology.
In contrast to the tyrosine motifs present in the HIV-2 and
SIV Nefs, the dileucine motif is highly conserved in all
HIV-1 alleles and, despite strong evolutionary pressure, a
corresponding leucine motif is also well conserved among
some HIV-2 and SIV alleles. Conservation of this leucine
motif suggests that it represents a key structural determi-
nant of Nef function. As HIV-1 and HIV-2/SIV have
evolved different strategies to interact with the cellular
adaptors underlying CD4 and MHC class I downregulation,
it will be of interest to determine whether the dileucine
motif exerts functional effects in the HIV-2/SIV system.
During the review of this manuscript, Craig and colleagues
[23] described similar findings regarding the dileucine
motif in HIV-1 and its function as an internalization signal.
Supplementary material
Additional methodological detail is published with this paper on 
the internet.
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Supplementary materials and methods
Monoclonal antibody 100/3, specific for the γ subunit of AP-1 (Sigma),
was used at a dilution of 1:500 for immunoblotting. OKT8 antibody
specific for the human CD8 antigen was obtained from A. Weiss
(UCSF, San Francisco). For fluorescence-activated cell sorting (FACS)
analysis of cell-surface receptors, anti-CD4–FITC, anti-CD4–PE, anti-
CD8–PE and anti-CD8–FITC were obtained from Becton Dickinson.
Anti-Hck monoclonal antibody was obtained from Transduction Labora-
tories. Anti-CD25–PE and anti-CD25–TC were obtained from Caltag.
Rabbit antiserum GF7 was generated to HIV-1 R7/3 Nef using a
recombinant Nef as the immunogen.
GST–Nef fusion proteins were expressed in the BL21 strain of
Escherichia coli using the pGEX2T vector (Pharmacia) and isolated
on glutathione–Sepharose 4B beads (Pharmacia). HeLa cell lysates
were prepared in lysis buffer (1% NP-40, 150 mM NaCl, 10 mM Tris
pH 7.4, 1 mM EDTA, 1 mM PMSF, 1× protease inhibitor cocktail
(Boehringer Mannheim)). For binding of p59Hck, 293 cells were trans-
fected with plasmid LNCX HCK p59 [S1], then harvested after 40 h
as described [13]. 
The plasmid pNL4-3 Nef HA was prepared by subcloning NL4-3 Nef
into the vector pCMV4neo [S2]. Site-directed mutants of both pNL4-3
Nef HA and pCN were created using the Bio-Rad Mutagene Kit
(BioRad). The plasmid pCD8 contains human CD8 in the pCMV4
vector [S2] and the plasmid pCN contains a CD8–SF2 Nef fusion
protein [12]. Wild-type or mutant NL4-3 nef genes were amplified by
PCR and inserted into pCN. 
The cDNAs for the IL-2Rα–Nef159–169 chimeras were prepared by PCR
of the IL-2Rα cDNA with DNA primers which extended the IL-2Rα cDNA
sequences to encode an additional 11 carboxy-terminal amino 
acids, GENTSL164L165HPVS or GENTSA164A165HPVS, at the 
carboxyl terminus. The plasmids pIL-2Rα–Nef159–169 and pIL-
2Rα–Nef159–169(LL164/165AA) were made by inserting these PCR products
into the pCMV4 vector. All constructs were verified by DNA sequencing. 
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